Total Research Group, LLC
United States
1. Duke University/Boehringer Ingelheim – Principle Investigator – Phase 3, A Multicenter International Randomized Parallel Group Double-Blind Placebo-Controlled Clinical Trial of XXX Once Daily To Assess Cardio-Renal Outcomes In Patients ...
- Size We are a clinical site adjacent to the PI's medical practice.
- Previous clinical trials More than 10
- Staff 11